Falls Predict Acute Hospitalization in Parkinson's Disease


Por: Santos García D, de Deus Fonticoba T, Cores C, Castro ES, Hernández Vara J, Jesús S, Mir P, Cosgaya M, Martí MJ, Pastor P, Cabo I, Seijo M, Legarda I, Vives B, Caballol N, Rúiz Martínez J, Croitoru I, Cubo E, Miranda J, Alonso Losada MG, Labandeira C, López Ariztegui N, Morales-Casado M, González Aramburu I, Infante J, Escalante S, Bernardo N, Blázquez Estrada M, Menéndez González M, Caldentey JG, Borrué C, Vela L, Catalán MJ, Gómez Mayordomo V, Kurtis M, Prieto C, Ordás C, Nogueira V, López Manzanares L, Ávila Rivera MA, Puente V, García Moreno JM, Solano Vila B, Álvarez Sauco M, Carrillo Padilla F, Carlos Martínez Castrillo J, Sánchez Alonso P, Gastón I, Kulisevsky J, Valero C, de Fábregues O, González Ardura J, López Díaz LM and Martinez-Martin P

Publicada: 1 ene 2023 Ahead of Print: 7 abr 2021
Resumen:
Background: There is a need for identifying risk factors for hospitalization in Parkinson's disease (PD) and also interventions to reduce acute hospital admission. Objective: To analyze the frequency, causes, and predictors of acute hospitalization (AH) in PD patients from a Spanish cohort. Methods: PD patients recruited from 35 centers of Spain from the COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015) cohort from January 2016 to November 2017, were included in the study. In order to identify predictors of AH, Kaplan-Meier estimates of factors considered as potential predictors were obtained and Cox regression performed on time to hospital encounter 1-year after the baseline visit. Results: Thirty-five out of 605 (5.8%) PD patients (62.5 +/- 8.9 years old; 59.8% males) presented an AH during the 1-year follow-up after the baseline visit. Traumatic falls represented the most frequent cause of admission, being 23.7% of all acute hospitalizations. To suffer from motor fluctuations (HR [hazard ratio] 2.461; 95% CI, 1.065-5.678; p = 0.035), a very severe non-motor symptoms burden (HR [hazard ratio] 2.828; 95% CI, 1.319-6.063; p = 0.008), falls (HR 3.966; 95% CI 1.757-8.470; p = 0.001), and dysphagia (HR 2.356; 95% CI 1.124-4.941; p = 0.023) was associated with AH after adjustment to age, gender, disease duration, levodopa equivalent daily dose, total number of non-antiparkinsonian drugs, and UPDRS-IIIOFF. Of the previous variables, only falls (HR 2.998; 95% CI 1.080-8.322; p = 0.035) was an independent predictor of AH. Conclusion: Falls is an independent predictor of AH in PD patients.

Filiaciones:
Santos García D:
 CHUAC, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain

de Deus Fonticoba T:
 CHUF, Complejo Hospitalario Universitario de Ferrol, A Coruña, Spain

Cores C:
 CHUAC, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain

Castro ES:
 CHUF, Complejo Hospitalario Universitario de Ferrol, A Coruña, Spain

Hernández Vara J:
 Neurology Department and Neurodegenerative Diseases Research. Vall D'Hebron Universitary Campus, Barcelona, Spain

Jesús S:
 Unidad de Trastornos del Movimiento, Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain

 CIBERNED (Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas), Spain

Mir P:
 Unidad de Trastornos del Movimiento, Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain

 CIBERNED (Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas), Spain

Cosgaya M:
 Hospital Clinic de Barcelona, Barcelona, Spain

Martí MJ:
 Hospital Clinic de Barcelona, Barcelona, Spain

Pastor P:
 Movement disorders Unit, University Hospital Mutua de Terrassa, Barcelona, Spain

Cabo I:
 Complejo Hospitalario Universitario de Pontevedra (CHOP), Pontevedra, Spain

Seijo M:
 Complejo Hospitalario Universitario de Pontevedra (CHOP), Pontevedra, Spain

Legarda I:
 Hospital Universitario Son Espases, Palma de Mallorca, Spain

Vives B:
 Hospital Universitario Son Espases, Palma de Mallorca, Spain

Caballol N:
 Consorci Sanitari Integral, Hospital Moisés Broggi, Sant Joan Despí, Barcelona, Spain

Rúiz Martínez J:
 Hospital Universitario Donostia, San Sebastián, Spain

Croitoru I:
 Hospital Universitario Donostia, San Sebastián, Spain

Cubo E:
 Complejo Asistencial Universitario de Burgos, Burgos, Spain

Miranda J:
 Complejo Asistencial Universitario de Burgos, Burgos, Spain

Alonso Losada MG:
 Hospital Álvaro Cunqueiro, Complejo Hospitalario Universitario de Vigo (CHUVI), Vigo, Spain

Labandeira C:
 Hospital Álvaro Cunqueiro, Complejo Hospitalario Universitario de Vigo (CHUVI), Vigo, Spain

López Ariztegui N:
 Complejo Hospitalario de Toledo, Toledo, Spain

Morales-Casado M:
 Complejo Hospitalario de Toledo, Toledo, Spain

González Aramburu I:
 Hospital Universitario Marqués de Valdecilla, Santander, Spain

Infante J:
 Hospital Universitario Marqués de Valdecilla, Santander, Spain

Escalante S:
 Hospital de Tortosa Verge de la Cinta (HTVC), Tortosa, Tarragona, Spain

Bernardo N:
 Hospital de Tortosa Verge de la Cinta (HTVC), Tortosa, Tarragona, Spain

Blázquez Estrada M:
 Hospital Universitario Central de Asturias, Oviedo, Spain

Menéndez González M:
 Movement disorders Unit, University Hospital Mutua de Terrassa, Barcelona, Spain

Caldentey JG:
 Centro Neurológico Oms, Palma de Mallorca, Spain

Borrué C:
 Hospital Infanta Sofía, Madrid, Spain

Vela L:
 Fundación Hospital de Alcorcón, Madrid, Spain

Catalán MJ:
 Hospital Universitario Clínico San Carlos, Madrid, Spain

Gómez Mayordomo V:
 Hospital Universitario Clínico San Carlos, Madrid, Spain

Kurtis M:
 Hospital Ruber Internacional, Madrid, Spain

Prieto C:
 Hospital Rey Juan Carlos, Madrid, Spain

Ordás C:
 Hospital Rey Juan Carlos, Madrid, Spain

Nogueira V:
 Hospital Da Costa, Burela, Lugo, Spain

López Manzanares L:
 Hospital Universitario La Princesa, Madrid, Spain

Ávila Rivera MA:
 Consorci Sanitari Integral, Hospital General de L'Hospitalet, L'Hospitalet de Llobregat, Barcelona, Spain

Puente V:
 Hospital del Mar, Barcelona, Spain

García Moreno JM:
 Hospital Universitario Virgen Macarena, Sevilla, Spain

Solano Vila B:
 Institut d'Assistència Sanitària (IAS) - Institut Català de la Salut. Girona, Spain

:
 Hospital General Universitario de Elche, Elche, Spain

Carrillo Padilla F:
 Hospital Universitario de Canarias, San Cristóbal de la Laguna, Santa Cruz de Tenerife, Spain

Carlos Martínez Castrillo J:
 Hospital Universitario Ramón Y Cajal, Madrid, Spain

Sánchez Alonso P:
 Hospital Universitario Puerta de Hierro, Madrid, Spain

Gastón I:
 Complejo Hospitalario de Navarra, Pamplona, Spain

Kulisevsky J:
 CIBERNED (Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas), Spain

 Hospital de Sant Pau, Barcelona, Spain

:
 Hospital Arnau de Vilanova, Valencia, Spain

de Fábregues O:
 Neurology Department and Neurodegenerative Diseases Research. Vall D'Hebron Universitary Campus, Barcelona, Spain

González Ardura J:
 Hospital Universitario Lucus Augusti (HULA), Lugo, Spain

López Díaz LM:
 Complejo Hospitalario Universitario de Orense (CHUO), Orense, Spain

Martinez-Martin P:
 CIBERNED (Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas), Spain
ISSN: 18777171





JOURNAL OF PARKINSONS DISEASE
Editorial
IOS Press, Netherlands, Países Bajos
Tipo de documento: Article
Volumen: 13 Número: 1
Páginas: 105-124
WOS Id: 000925034100010
ID de PubMed: 33843696
imagen gold, Green Published

MÉTRICAS